Table 3.
Therapeutic management and complications
| Variable | Global (N) | Number of controls | Number of cases |
|---|---|---|---|
| Functional treatments (N = 36); P = 0.000 | Cataract surgery + PFV (8) 8 0 Retina surgery (1) |
1 | 0 |
| External rehabilitation (N = 36) | External conformera (23) P = 0.003 |
1 | 22 |
| Canthotomy (6) | 0 | 6 | |
| Conjunctival sac reconstruction (6) | 0 | 6 | |
| Tarsorraphy (10) | 0 | 10 | |
| Internal rehabilitation (N = 36) | Enucleation (8) | 0 | 8 |
| Internal prosthesis (9) P = 0.006 |
0 | 9 | |
| Oral mucous graft (6) | 0 | 6 | |
| Calvarial bone graft (2) | 0 | 2 | |
| Dermafat graft (5) | 0 | 5 | |
| Orbital expansion (3) | 0 | 3 | |
| Complications | Implant infection (N = 9): (2) | 0 | 2 |
| Internal prosthesis exposure (N = 9): (2) | 0 | 2 | |
| Ptosis (N = 36): (10) P = 0.003 |
0 | 10 |
Notes: P-values are between groups.
a
When both eyes were affected, only the most severe was considered (being the most susceptible to further surgical intervention), except for one patient with OS anophthalmia and OD microphthalmia with superior eyelid agenesis and acceptable vision. This patient was considered as a “control” because surgical procedures were performed on his best eye (OD), including application of a modified external conformer (in this variable, n = 23 “cases”).
Abbreviations: OD, right; OS, left; PFV, persistent fetal vasculature.